Search
Insulet Corp
PODDAdd to Watchlist
145.650USD
+2.130+1.48%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
10.10BMarket Cap
33.79P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Insulet Corp is 8.50, ranking 28 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 380.00, with a high of 432.00 and a low of 316.00.
Analyst Rating
Based on
28
analysts
Buy
Current Rating
262.445
Target Price
+77.16%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Insulet Corp
PODD
28
Medtronic PLC
MDT
33
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Insulet Corp's expected revenue for the next quarter?
Insulet Corp's expected revenue is 787.45M.
What is Insulet Corp's price target?
Analysts forecast that Insulet Corp's price target is USD 380.00, with the highest forecast at USD 432.00 and the lowest forecast at USD 316.00.
How have Insulet CorpPODD's recent earnings per share performed?
The market expectation was USD 1.30, while Insulet CorpPODD's earnings per share (EPS) for the previous quarter was USD 1.44. EPS for the next quarter is expected at USD 1.45.
What is the analyst rating for Insulet Corp?
Based on the ratings of Insulet Corp's stock from 28 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
